|This message contains images. If you don't see images, click here to view.|
Advertise in this news brief.
Meet Pharma's Newest Movers and Shakers
The Wall Street Journal
A few years ago, the drug companies dominating mergers-and-acquisitions headlines were largely household names, from Pfizer Inc. and Merck & Co. to Novartis AG.
These days, a new generation of deal makers is making news, with names distinctly less familiar: Actavis PLC, Endo International PLC and Valeant Pharmaceuticals International Inc. Within the past few weeks, two other relatively under-the-radar companies, Mylan NV and Teva Pharmaceutical Industries Ltd., also entered the fray.
Get To Know The Designer Drug N-Bomb And Its Effects
By Lynn Hetzler
Recreational use of designer psychoactive drugs is rising dramatically. Designer drugs have gained popularity since law enforcement and legislation have made it more difficult for recreational users to secure cocaine, ecstasy, heroin, opioids and cannabis. These restrictions have encouraged suppliers and users to seek alternatives.
Illicit drug makers usually create designer drugs by modifying the molecular structures of existing illegal drugs in hopes of producing similar effects.
Generic Drug Maker Perrigo Could Be Targeted By Other Large Pharmaceutical Companies
In the deep-water world of pharmaceutical mergers and acquisitions, there may be other big fish interested in swallowing generic and store-brand products maker Perrigo Co. PLC.
According to Bloomberg Business News, there is an indication that one big fish, Israeli-based Teva Pharmaceuticals Industries Ltd., may be looking to buy Mylan NV, the company that wants to buy Perrigo.
Mentoring And Leading Go Hand In Hand
By Betty Boyd
Leadership is an opportunity to give back, and mentoring is the best way to build future leaders. Mentoring allows leaders to pass on their knowledge, which benefits both those being mentored and the organization.
Mentoring is an opportunity that should not be taken lightly. It is a way forward in achieving the dreams and goals for both individuals and the organization.
Nine Surprising Tips For Getting Ahead In Your Career
We all know to "go the extra mile," and to be "the first to arrive and the last to leave."
Cliché career advice gets old, and ultimately loses it's significance, so we turned to a recent Quora thread that asked users for advice that no one ever mentions.
Mylan Says It Is Opposed To Possible Teva Pharmaceuticals Merger
Generic drugmaker Mylan wants to put speculation of a possible merger with Teva Pharmaceuticals to rest. A potential deal, the company said, is “without sound industrial logic” and would have a hard time winning anti-trust clearances.
Mylan’s comments responded to reports from both Bloomberg and the Wall Street Journal that indicated Teva Pharmaceutical is considering a bid for the company.
Smart Ways To Stand Out, Get Noticed And Hired!
Business 2 Community
Everyone wants to stand out and be viewed as an ideal candidate during the hiring process. But the problem is, most people don’t know the best way of doing this. Many assume that to impress they need to emphasize that they graduated from a prestigious school or worked for a famous brand named company. Research shows that these credentials are only beneficial to a perspective candidate if they compliment accomplishments that matter to an employer.
Medical Campus Biotech Company Pursues Big Pharma Licensing Partners
Buffalo Business First
CH3 Biosystems has identified a new business strategy and is seeking to license its technology to large pharmaceutical partners.
The company’s patented technology helps identify drug and diagnostic candidates, and it has spent nearly seven years building its own molecular tools for the purpose of research into various grave diseases, including cancer.
Best Career Advice: Find a Need and Fill It
The Huffington Post
Author Jack Nadel writes: After seven decades as a successful entrepreneur, I would like to pass on what has been the most valuable piece of career advice I've ever come across. It has proven itself again and again despite changing economic conditions, market locations, employment trends or industry type.
At-Risk Children Given Oral Insulin To Develop Diabetes Immunity
The Pharmaceutical Journal
Oral insulin powder was given to children with a high genetic risk of developing Type 1 diabetes, as part of a phase I clinical trial, which researchers claim brings them a step closer to a vaccine.
The international Pre-Point study, published in JAMA on 21 April 2015, tested daily doses of oral insulin powder in children aged between 18 months and seven years with a genetic propensity for developing Type 1 diabetes but who did not have any evidence of autoimmune antibodies.
AAPS Career Services
Colby Horton, Vice President of Publishing, MultiBriefs, 469.420.2601
Download media kit
Jessica Taylor, Medical Editor, MultiBriefs, 202.684.7169
Be sure to add us to your address book or safe sender list so our emails get to your inbox. Learn how.
This edition of the AAPS Pharmaceutical Career News was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
April 10, 2015
March 27, 2015
March 13, 2015
Feb. 27, 2015
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063